Get started
BRISTOL-MYERS SQUIBB COBRISTOL-MYERS SQUIBB COBRISTOL-MYERS SQUIBB CO

BRISTOL-MYERS SQUIBB CO

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

BMY chart


Full chart

Key facts today


Bristol Myers Squibb's Sotyktu application for psoriatic arthritis treatment is under FDA review, with a decision expected by March 6, 2026, and also reviewed in Europe, China, and Japan.
Analyze the impactAnalyze the impact

Check out other big names from the same industry as BMY.

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BMY is 900.00 MXN — it has increased by 0.02% in the past 24 hours. Watch BRISTOL-MYERS SQUIBB CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BRISTOL-MYERS SQUIBB CO stocks are traded under the ticker BMY.
BMY stock has fallen by −0.42% compared to the previous week, the month change is a −2.18% fall, over the last year BRISTOL-MYERS SQUIBB CO has showed a 17.55% increase.
Yes, you can track BRISTOL-MYERS SQUIBB CO financials in yearly and quarterly reports right on TradingView.
BRISTOL-MYERS SQUIBB CO is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
BMY earnings for the last quarter are 36.88 MXN per share, whereas the estimation was 30.62 MXN resulting in a 20.43% surprise. The estimated earnings for the next quarter are 19.98 MXN per share. See more details about BRISTOL-MYERS SQUIBB CO earnings.
BRISTOL-MYERS SQUIBB CO revenue for the last quarter amounts to ‪229.48 B‬ MXN, despite the estimated figure of ‪219.11 B‬ MXN. In the next quarter, revenue is expected to reach ‪212.62 B‬ MXN.
Like other stocks, BMY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRISTOL-MYERS SQUIBB CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRISTOL-MYERS SQUIBB CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRISTOL-MYERS SQUIBB CO stock shows the sell signal. See more of BRISTOL-MYERS SQUIBB CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.